Electrophysiological Evaluation of Voluntary Attention

NCT ID: NCT02567201

Last Updated: 2024-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

214 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-16

Study Completion Date

2024-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim : To assess the ability of healthy subjects and patients with a severe motor disability to voluntary control their attention

Material and Methods:

Population: healthy subjects, patients with brain injury Electroencephalographic study to research attentional modulation during different kind of stimulation (visual, auditory, tactile)

Sudy 1: passive recording.

Study 2: active recording (instruction of attentional control given to the subject).

Study 3: active recording with a feedback obtained after a processing of the brain activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Injury

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Voluntary attention Electroencephalogram Brain-computer interface Disorders of consciousness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electrophysiological assessment of Healthy subjects

Experiences 1, 2 and 3 with healthy subjects

Group Type EXPERIMENTAL

electrophysiological evaluation

Intervention Type OTHER

electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1, 2, 3 : one session maximum by experience

Electrophysiological assessment of patients

Experiences 1, 2 and 3 with patients

Group Type EXPERIMENTAL

electrophysiological evaluation of patients

Intervention Type OTHER

electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 2 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 3 : Stimulation = auditory or visual ; possibility of several sessions if the patient is tired.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electrophysiological evaluation

electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1, 2, 3 : one session maximum by experience

Intervention Type OTHER

electrophysiological evaluation of patients

electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 2 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 3 : Stimulation = auditory or visual ; possibility of several sessions if the patient is tired.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults, man or woman, left or right-handed, from 18 years old to 80 years-old ;
* Diagnosis :

* Locked-in syndrome :

\< Brainstem injury, without any evolution for at least 3 week, etiology : vascular, traumatic \< Amyotrophic Lateral Sclerosis \< Following damage to the central or peripheral nervous system

* Or Minimal conscious state or Unresponsive Wakefulness Syndrome consecutive to a severe acquired brain injury for at least one month
* Or with a severe brain injury, since birth or acquired, for at least one month
* Or with Guillain-Barré syndrome

* Subjects affiliated to social security;
* Signature of consent form by the patient or by a relative (family member or "the trusted person") if obtaining a consent is impossible


* Adults, man or woman, left or right-handed, from 18 years old to 80 years-old ;
* Without known auditory impairment
* Subjects able to understand the experimental instructions
* Subjects affiliated to social security;
* Signature of consent form

Exclusion Criteria

* Medical history : psychiatric disorders (except if due to brain injury), neurologic disorders (except if due to brain injury)
* For healthy subjects : history of brain injury
* Pregnant women or breastfeeding women
* Person under legal protection
* Medico-legal conflicts
* Absence of consent by the subject or the patient or his/her representant
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jacques LUAUTE, MD

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Médical de L'argentière

Aveize, , France

Site Status

Centre Hospitalier Georges Claudinon

Le Chambon-Feugerolles, , France

Site Status

Hospices Civils de Lyon

Lyon, , France

Site Status

Centre de Recherche en Neurosciences de Lyon

Lyon, , France

Site Status

CHU de Nantes

Nantes, , France

Site Status

CHU de Nîmes

Nîmes, , France

Site Status

APHP - Hôpital de la Pitié Salpêtrière

Paris, , France

Site Status

APHP - Hôpital Raymond Poincaré

Paris, , France

Site Status

Hôpital Nord CHU Saint Etienne

Saint-Etienne, , France

Site Status

Hospices civils de Lyon, Hôpital Henry Gabrielle,

Saint-Genis-Laval, , France

Site Status

Centre Médical Germaine Revel

Saint-Maurice-sur-Dargoire, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Seguin P, Maby E, Fouillen M, Otman A, Luaute J, Giraux P, Morlet D, Mattout J. The challenge of controlling an auditory BCI in the case of severe motor disability. J Neuroeng Rehabil. 2024 Jan 18;21(1):9. doi: 10.1186/s12984-023-01289-3.

Reference Type DERIVED
PMID: 38238759 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-A00635-44

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL15_0216

Identifier Type: -

Identifier Source: org_study_id